引導式測驗 · 中等 等級

糖尿病視網膜病變篩檢之 AI 應用測驗

測試設備特定授權、影像品質故障、轉診途徑、篩檢限制以及綜合眼科檢查的持續作用。

問題 1 的 8

Under IDx-DR's FDA-authorized intended use, which patient and imaging scope is specified?

預覽每個問題8 問題

當您參加測驗時,就會出現答案和解釋。

  1. Under IDx-DR's FDA-authorized intended use, which patient and imaging scope is specified?
    • Adults with diabetes and no prior diabetic-retinopathy diagnosis, imaged with the specified Topcon NW400 to detect more-than-mild retinopathy
    • Any age with diabetes, using any fundus camera to detect all stages of retinopathy
    • Adults already diagnosed with retinopathy, using the NW400 to determine treatment response
    • Adults without diabetes, using smartphone photos to screen for glaucoma and retinopathy
  2. What does FDA authorization for IDx-DR apply to?
    • Every AI application that analyzes eye photographs
    • Any camera and patient population without validation
    • Treatment of diabetic retinopathy
    • A specific device, intended use, image workflow, and labeling
  3. How should a positive screening result be handled under IDx-DR labeling?
    • Skip follow-up if the patient has no symptoms
    • Refer the patient to an eye-care provider for further evaluation and care
    • Treat the disease automatically from the AI result
    • Assume the patient has glaucoma
  4. What does a no-result or poor-quality image mean?
    • It confirms that the retina is normal
    • It should be discarded without further action
    • The screening was not completed and retest or referral is needed per labeling
    • It is equivalent to a negative screen
  5. Which claim about IDx-DR would be unsupported by its FDA-labeled intended use?
    • It is intended for eligible adults with diabetes and no prior diabetic-retinopathy diagnosis
    • It screens retinal images for more-than-mild diabetic retinopathy
    • It uses retinal images captured with the specified Topcon NW400 camera
    • It also screens for glaucoma
  6. Does a negative AI screen replace regular eye-care recommendations?
    • Yes, it screens for every eye disease
    • No, but only if the camera is not connected to Wi-Fi
    • No; people with diabetes should continue appropriate comprehensive eye exams
    • Yes, it guarantees future eye health
  7. Why are image-quality checks part of the screening workflow?
    • The algorithm needs suitable retinal photographs to generate a usable result
    • They allow the device to diagnose diabetes
    • They replace referral for a positive screen
    • They make every camera compatible automatically
  8. What should a clinic measure after adopting an AI eye-screening device?
    • The number of AI terms in a patient leaflet
    • Ungradable images, referral completion, and performance in the intended population
    • Only the number of images uploaded
    • Only the device’s purchase price